NEW YORK (AP) -- CVS Caremark says it will pay $5 million to resolve allegations that one of its subsidiaries understated the price of several drugs on a Medicare website.
The payment will be used to reimburse Medicare prescription drug beneficiaries who paid more than they expected for the drugs, and it ends an investigation by the Federal Trade Commission. CVS Caremark Corp. says its Rx America business accidentally published incorrect drug price information on a site maintained by Medicare.
In some cases, the actual prices were 10 times higher than the listed prices, the agency said.
The FTC says drugs for which Rx America posted wrong prices included treatments for breast cancer symptoms and epilepsy. The drugs were sold at CVS and Walgreen Co. stores.
KKTV firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKTV 11 News.
If you believe that any of the comments on our site are inappropriate or offensive, please tell us by clicking “Report Abuse” and answering the questions that follow. We will review any reported comments promptly.powered by Disqus